Metformin: therapeutic option in people at high cardiometabolic risk
42,60 €*
Sofort verfügbar, Lieferzeit: 1-3 Tage
Produktnummer:
9783659842092
The topic of this book is prevention of type 2 diabetes mellitus and cardiovascular disease which are increasing by epidemic proportions all over the world. Metabolic syndrome is well established risk factor for type 2 diabetes mellitus and cardiovascular disease. Hyperinsulinaemia is considered as the earliest stage of development of type 2 diabetes and a core defect unifying the cardiovascular cluster of the metabolic syndrome. Treatment of the metabolic syndrome and hyperinsulinaemia is essential for the prevention of type 2 diabetes and cardiovascular disease. Metformin is a medication of first choice in therapeutic strategy of type 2 diabetes. The book comprises of two research articles representing results of metformin treatment in people at high risk for development of type 2 diabetes mellitus and cardiovascular disease such as those with hyperinsulinaemia, normal glucose tolerance and metabolic syndrome.
| Autor: | Kamenova, Petya |
|---|---|
| EAN: | 9783659842092 |
| Sprache: | Englisch |
| Seitenzahl: | 52 |
| Produktart: | kartoniert, broschiert |
| Verlag: | Scholar's Press Scholars' Press |
| Schlagworte: | Medizin Metformin |
| Größe: | 3 × 150 × 220 |
| Gewicht: | 86 g |
